Skip to content

Cancer Referral Overview Page

Outline

To open a Referral and see an overview – click on the Referral ID in the Referral Grid for the case you wish to review.

Image

Key
# Section Description
1 Patient Summary The Referral ID for the patient.
2 Referral Priority Priority for the case, e.g. “Routine” or “Urgent”.
3 Case Status Interpretation Status of the case, e.g. whether or not it is has a SoF ready.
4 Workflow status The workflow status for the referral.
5 Patient Link out to TOMS. If available, PID will be queried from TOMS and displayed here.
6 Interpretation Flags This flag describes the TINC status of the sample.
7 Interpretation Services List of the interpretation services that have been applied to the case.
8 Sex The sex of the patient.
9 Patient Choice Yes- patient has agreed to the test, No- patient has declined the test, NA- patient choice not relevant.
10 Interpreting Organisation Defined during test ordering.
11 Requesting Organisation Defined during test ordering.
12 Notes Notes added to the case during Test Order.
13 Cancer bridge DSS Links out Cancer Decision Support System
New Feature: TINC
  • TINC High: The germline sample for this patient is likely to be contaminated with DNA derived from the tumour. Consequently, the sensitivity of somatic variant detection may be reduced, potentially resulting in an increased risk of false negative findings. To mitigate the potential loss in sensitivity, the results of somatic variant calling with an unmatched germline sample are included in this analysis alongside subtraction with the patient’s germline sample.
  • TINC Low: The germline sample for this patient is likely to be contaminated with DNA derived from the tumour. Consequently, the sensitivity of somatic variant detection may be reduced, potentially resulting in an increased risk of false negative findings. To mitigate the potential loss in sensitivity, the results of somatic variant calling with an unmatched germline sample are included in this analysis alongside subtraction with the patient’s germline sample.
  • TINC Error: The results of the computational estimation of tumour in normal contamination (TINC) are not reliable for this patient (which may be due to low tumour content in the tumour sample, or very high tumour contamination in the germline sample). Consequently, TINC cannot be excluded and the sensitivity of somatic variant detection may be reduced, potentially resulting in an increased risk of false negative findings. To mitigate the potential loss in sensitivity, the results of somatic variant calling with an unmatched germline sample are included in this analysis alongside subtraction with the patient’s germline sample.

For further information on the TINC pipeline please refer to the Cancer Genome Analysis Guide

Functionality

The Cancer Referral Overview enables users to:

  • Link out to Cancer Decision Support System (cDSS)

    In addition to the Primary and Supplementary HTML files, from the Cancer Referral Overview page users can link to the Cancer Decision Support System (cDSS) to review variants.

    Note

    In BSVI it was possible to create a new Summary of Findings, however, this created duplicate work for Clinical Scientists. In the new cDSS it is not possible to create a Summary of Findings and the HTML report generated by the bioinformatics pipeline should be used as the Summary of Findings". Please see the cDSS user guide for further information.

  • Download Feedback forms and Files

    From the Cancer Referral Overview page users can access the Cancer Referral Feedback form

    Any files associated with the referral can be downloaded from here, including the Primary and Supplementary HTML files

Cancer file download

From the main cancer case page the associated cancer files can be downloaded.

Image

For additional technical details of the Cancer Reports please refer to Technical Documentation available for download here and the Cancer Genome Analysis Guide


Last update: 2024-05-17